Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
Puéchal X, Pagnoux C, Perrodeau É, Hamidou M, Boffa JJ, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P, Hanrotel-Saliou C, Imbert B, Khouatra C, Lambert M, Leské C, Ly KH, Pertuiset E, Roblot P, Ruivard M, Subra JF, Viallard JF, Terrier B, Cohen P, Mouthon L, Le Jeunne C, Ravaud P, Guillevin L; French Vasculitis Study Group. Puéchal X, et al. Among authors: imbert b. Arthritis Rheumatol. 2016 Mar;68(3):690-701. doi: 10.1002/art.39450. Arthritis Rheumatol. 2016. PMID: 26473755 Free article. Clinical Trial.
Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa.
Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, Imbert B, Hausfater P, Roudier J, Bielefeld P, Petitjean P, Smadja D; French Vasculitis Study Group. Guillevin L, et al. Among authors: imbert b. Arthritis Rheum. 2004 Jun 15;51(3):482-7. doi: 10.1002/art.20401. Arthritis Rheum. 2004. PMID: 15188337 Free article. Clinical Trial.
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Mouthon L, Hatron PY, Jego P, Allanore Y, Tiev KP, Agard C, Cosnes A, Cirstea D, Constans J, Farge D, Viallard JF, Harle JR, Patat F, Imbert B, Kahan A, Cabane J, Clerson P, Guillevin L, Humbert M; Itinér AIR-Sclérodermie Study Group. Hachulla E, et al. Among authors: imbert b. Arthritis Rheum. 2009 Jun;60(6):1831-9. doi: 10.1002/art.24525. Arthritis Rheum. 2009. PMID: 19479881 Free article.
Sustained Remission of Granulomatosis With Polyangiitis After Discontinuation of Glucocorticoids and Immunosuppressant Therapy: Data From the French Vasculitis Study Group Registry.
Puéchal X, Iudici M, Pagnoux C, Karras A, Cohen P, Maurier F, Quéméneur T, Lifermann F, Hamidou M, Mouthon L, Terrier B, Guillevin L; French Vasculitis Study Group. Puéchal X, et al. Arthritis Rheumatol. 2021 Apr;73(4):641-650. doi: 10.1002/art.41551. Epub 2021 Feb 28. Arthritis Rheumatol. 2021. PMID: 33029946
On-Demand Sildenafil as a Treatment for Raynaud Phenomenon: A Series of n-of-1 Trials.
Roustit M, Giai J, Gaget O, Khouri C, Mouhib M, Lotito A, Blaise S, Seinturier C, Subtil F, Paris A, Cracowski C, Imbert B, Carpentier P, Vohra S, Cracowski JL. Roustit M, et al. Among authors: imbert b. Ann Intern Med. 2018 Nov 20;169(10):694-703. doi: 10.7326/M18-0517. Epub 2018 Oct 30. Ann Intern Med. 2018. PMID: 30383134 Clinical Trial.
Efficacy and Safety of Botulinum Toxin in Adults with Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
Senet P, Maillard H, Diot E, Lazareth I, Blaise S, Arnault JP, Pistorius MA, Boulon C, Cogrel O, Warzocha U, Rivière S, Malloizel-Delaunay J, Servettaz A, Sassolas B, Viguier M, Monfort JB, Janique S, Vicaut E; BRASS collaborators. Senet P, et al. Arthritis Rheumatol. 2023 Mar;75(3):459-467. doi: 10.1002/art.42342. Epub 2022 Dec 14. Arthritis Rheumatol. 2023. PMID: 36066501 Clinical Trial.
Reproducibility of capillaroscopic classifications of systemic sclerosis: results from the SCLEROCAP study.
Boulon C, Devos S, Mangin M, Decamps-Le Chevoir J, Senet P, Lazareth I, Baudot N, Tribout L, Imbert B, Blaise S, Sintes P, Lapebie FX, Lacroix P, Truchetet ME, Seneschal J, Solanilla A, Skopinski S, Lazaro E, Quéré I, Pistorius MA, Le Hello C, Perez P, Carpentier P, Constans J. Boulon C, et al. Among authors: imbert b. Rheumatology (Oxford). 2017 Oct 1;56(10):1713-1720. doi: 10.1093/rheumatology/kex246. Rheumatology (Oxford). 2017. PMID: 28957554
Reproducibility of the scleroderma pattern assessed by wide-field capillaroscopy in subjects suffering from Raynaud's phenomenon.
Boulon C, Blaise S, Lazareth I, Le Hello C, Pistorius MA, Imbert B, Mangin M, Sintes P, Senet P, Decamps-Le Chevoir J, Tribout L, Carpentier P, Constans J. Boulon C, et al. Among authors: imbert b. Rheumatology (Oxford). 2017 Oct 1;56(10):1780-1783. doi: 10.1093/rheumatology/kex282. Rheumatology (Oxford). 2017. PMID: 28957564
Comment on: Reproducibility of the scleroderma pattern assessed by wide-field capillaroscopy in subjects suffering from Raynaud's phenomenon: reply.
Constans J, Blaise S, Lazareth I, Le Hello C, Pistorius MA, Imbert B, Mangin M, Sintes P, Senet P, Decamps-Le Chevoir J, Tribout L, Carpentier P, Boulon C. Constans J, et al. Among authors: imbert b. Rheumatology (Oxford). 2018 May 1;57(5):941-942. doi: 10.1093/rheumatology/kex483. Rheumatology (Oxford). 2018. PMID: 29390130 No abstract available.
97 results